Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA3752534
Max Phase: Preclinical
Molecular Formula: C58H78N14O10
Molecular Weight: 1131.35
Molecule Type: Protein
Associated Items:
ID: ALA3752534
Max Phase: Preclinical
Molecular Formula: C58H78N14O10
Molecular Weight: 1131.35
Molecule Type: Protein
Associated Items:
Canonical SMILES: CCCC[C@H](NC(C)=O)C(=O)N[C@H]1CC(=O)NCCCC[C@@H](C(N)=O)NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](Cc2ccc3ccccc3c2)NC(=O)[C@@H]2CCCN2C(=O)[C@@H]2CCCN2C1=O
Standard InChI: InChI=1S/C58H78N14O10/c1-3-4-17-42(65-34(2)73)51(76)70-46-32-49(74)62-25-10-9-19-41(50(59)75)66-54(79)45(31-38-33-64-40-18-8-7-16-39(38)40)68-52(77)43(20-11-26-63-58(60)61)67-53(78)44(30-35-23-24-36-14-5-6-15-37(36)29-35)69-55(80)47-21-12-27-71(47)57(82)48-22-13-28-72(48)56(46)81/h5-8,14-16,18,23-24,29,33,41-48,64H,3-4,9-13,17,19-22,25-28,30-32H2,1-2H3,(H2,59,75)(H,62,74)(H,65,73)(H,66,79)(H,67,78)(H,68,77)(H,69,80)(H,70,76)(H4,60,61,63)/t41-,42-,43-,44+,45-,46-,47-,48-/m0/s1
Standard InChI Key: OMSSRUBSGSKAFS-IPIAHOSKSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Protein | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 1131.35 | Molecular Weight (Monoisotopic): 1130.6025 | AlogP: | #Rotatable Bonds: |
Polar Surface Area: | Molecular Species: | HBA: | HBD: |
#RO5 Violations: | HBA (Lipinski): | HBD (Lipinski): | #RO5 Violations (Lipinski): |
CX Acidic pKa: | CX Basic pKa: | CX LogP: | CX LogD: |
Aromatic Rings: | Heavy Atoms: | QED Weighted: | Np Likeness Score: |
1. Carotenuto A, Merlino F, Cai M, Brancaccio D, Yousif AM, Novellino E, Hruby VJ, Grieco P.. (2015) Discovery of Novel Potent and Selective Agonists at the Melanocortin-3 Receptor., 58 (24): [PMID:26599352] [10.1021/acs.jmedchem.5b01285] |
2. Gimenez LE, Noblin TA, Williams SY, Mullick Bagchi S, Ji RL, Tao YX, Jeppesen CB, Conde-Frieboes KW, Sawyer TK, Grieco P, Cone RD.. (2022) Demonstration of a Common DPhe7 to DNal(2')7 Peptide Ligand Antagonist Switch for Melanocortin-3 and Melanocortin-4 Receptors Identifies the Systematic Mischaracterization of the Pharmacological Properties of Melanocortin Peptides., 65 (8.0): [PMID:35404053] [10.1021/acs.jmedchem.1c01295] |
Source(1):